{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Return to Main Site
Client logo
  • Sign In
  • Live Activities
  • Scheduled Series
  • Online Activities
  • Learning From Teaching
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Select Login Provider

You can login with your Organization's directory account, or use your CloudCME™ account:




Enter your email and password to login:








Forgot Your Password? | Don't have an account?
Go back to providers list button Go Back to Provider Selection

Please login with the email address you used to register with earlier. If you already have an account and create a new one, your credits will not appear combined on one transcript. If you cannot remember your password, please use the password recovery to retrieve it.

System does not require a IU CAS login.

Forgot Your Password?






Go back to login button Go Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Need an Account?

Enter Your Information. *All fields are required.








Please enter your degree:

*Profession can be updated in the “My Profile” area

*Additional credit eligibilities can be updated in the “My Profile” area

Empty Box that can be used later for a new control but makes the formatting work now instead of a bunch of random CSS



Go Back to Login button Go Back to Login
Close Search
Site Search: Enter your search terms in the field below to view results.
Close Specialties

HCV Treatment in Patients With Advanced Liver Disease: Who, How, and When?

HCV Treatment in Patients With Advanced Liver Disease: Who, How, and When? Banner

  • Overview
  • Faculty
  • Tests
Add to Calendar HCV Treatment in Patients With Advanced Liver Disease: Who, How, and When? 10/1/2018 12:00:00 AM 10/1/2019 12:00:00 AM America/New_York false MM/DD/YYYY


Date & Location
Monday, October 1, 2018, 12:00 AM - Tuesday, October 1, 2019, 12:00 AM

Overview
This activity provides an overview of available therapeutic regimens for treatment-naïve patients with HCV infection and stage F2 or lower liver disease. Dr. Kwo also discusses the recommended monitoring that should occur during and after treatment, as well as the opportunity for cure among people who use injection drugs.
Objectives
  1. Describe treatment potential for patients with HCV and advanced liver disease.

Registration

Go here to view this activity 

For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.

To receive credit, read the introductory CME material, listen to the audiocast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.


Accreditation

Accreditation Statement

In support of improving patient care, Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

Indiana University School of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This CME activity has been developed in partnership with Med-IQ.

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or cme@iu.edu. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

The registration form for this activity Is currently unavailable.

Indiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that IUSM may identify and resolve any conflicts of interest prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.

*Indiana University School of Medicine (IUSM) defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

To view any relevant financial relationships with commercial interests for anyone who was in control of the content of this activity, please click the names below.  All conflicts were resolved in accordance with ACCME and the IUSM Conflict of Interest Policy
.

Paul Y Kwo, MD
Stanford University
Palo Alto, CA

HCV Treatment in Patients With Advanced Liver Disease: Who, How, and When?


 CONTACT

410 W 10th Street, Indianapolis, IN 46202
317-274-0104 | 1-888-615-8013
medicine.iu.edu/education/cme
cme@iu.edu

Copyright © 2018 The Trustees of Indiana University
Copyright Complaints | Privacy Notice